Steering Committee

  • Robert Capon, Senior Vice President, Adenosine Therapeutics Group, PGxHealth
  • Doug Doerfler, President and CEO, MaxCyte, Inc.
  • Joe Hernandez, Chairman, Principio
  • Ron Laufer, M.D., Senior Managing Director, MedImmune Ventures
  • Brandon Price, Ph.D., Principal Consultant, Falcon Ridge Associates
  • Bruce Robertson, Managing Director, H.I.G. Ventures
  • Ryan Schwarz, Managing Director, The Carlyle Group
  • Dietrich Stephan, Ph.D., CEO, Ignite Institute
  • Brad L. Stewart, President, Cylex